Mrinalini Patil, MD
- Assistant Professor, CWRU School of Medicine
- Specialty: Vascular Surgery
-
Location:UH Cleveland Medical Center Mather
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3013
Biography: Mrinalini Patil, MD
Education
Fellowship | Vascular Surgery
Vascular Surgery - University Of Nebraska Medical Center (2022 - 2024)
Residency | General Surgery
General Surgery - University Of Kansas Medical Center And School Of Medicine (2017 - 2022)
Medical Education
University Of Oklahoma College Of Medicine (2013 - 2017)
Undergraduate
Oklahoma State University (2013)
About
Mrinalini Patil, MD, is a board-certified vascular surgeon and endovascular specialist at University Hospitals Harrington Heart & Vascular Institute. She is skilled in performing the full range of open and minimally invasive surgical procedures for patients with vascular conditions including aortic disease, carotid artery disease, venous disease and peripheral artery disease.
Dr. Patil earned her medical degree from the University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. She participated in a global surgery program at Mzuzu Central Hospital in Malawi, Africa, before pursuing a general surgery residency at the University of Kansas Medical Center in Kansas City, Kansas, where she was recognized as Outstanding Resident of the Year. She then completed a vascular surgery fellowship at the University of Nebraska Medical Center in Omaha, Nebraska.
A prolific author, Dr. Patil has co-authored numerous publications on vascular related treatment techniques such as thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injury and carotid endarterectomy for carotid artery disease.
Dr. Patil is an active member of the Midwestern Vascular Surgical Society and the Society for Vascular Surgery.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Mrinalini Patil did not disclose any Outside Relationships with Industry.